The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSafeCharge Regulatory News (SCH)

  • There is currently no data for SCH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (SafeCharge International Group)

31 May 2019 15:30

RNS Number : 8108A
SafeCharge International Group Ltd
31 May 2019
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

SafeCharge International Group Limited ("SafeCharge")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SafeCharge International Group Limited

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

30 May 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

 

TOTAL:

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Ordinary Shares held by the directors of SafeCharge

 

Director

No. of Ordinary Shares of $0.0001 held

% of issued share capital

David Avgi

3,374,1111

2.21

Yuval Ziv

7,0402

0.005

Roger Withers

31,5643

0.02

John Le Poidevin

30,8644

0.02

 

1 Pershing Nominees Limited is the registered holder of 374,111 Ordinary Shares which are held as nominee for Foxberry Limited, which is ultimately owned by a trust, the beneficiary of which is David Avgi. Israel Brokerage and Investments, I.B.I Ltd holds the remaining 3,000,000 Ordinary Shares as trustee for David Avgi.

 

2 Vidacos Nominees Limited is the registered holder of 7,040 Ordinary Shares which are held as nominee for Yuval Ziv.

 

3 Barclays Direct Investing Nominees Limited is the registered holder of 31,564 Ordinary Shares which are held as nominee for Roger Withers.

 

4 Huntress (CI) Nominees Ltd. is the registered holder of 30,864 Ordinary Shares which are held as nominee for John Le Poidevin.

 

(b) 2011 Global Share Option Plan ("GSOP") awards held by the directors of SafeCharge

 

(i) GSOP awards (in the form of options in respect of SafeCharge Ordinary Shares) held by Yuval Ziv

 

Date of Grant

Earliest Vesting Date

Expiry Date

Exercise price (pence)

No. of Ordinary Shares subject to share awards

28 January 2014

28 January 2015

28 January 2024

121.0

166,667

9 September 2014

9 September 2015

9 September 2024

225.5

134,398

 

 

(ii) GSOP awards (in the form of options in respect of SafeCharge Ordinary Shares) held by Tsach Einav

 

Date of Grant

Earliest Vesting Date

Expiry Date

Exercise price (pence)

No. of Ordinary Shares subject to share awards

28 January 2014

28 January 2015

28 January 2024

121.0

83,334

9 September 2014

9 September 2015

9 September 2024

225.5

374,398

 

 

(c) Long Term Incentive Plan ("LTIP") awards held by the directors of SafeCharge

 

(i) LTIP awards (in the form of options in respect of SafeCharge Ordinary Shares) held by David Avgi1

 

Date of Grant

Vesting Date

Expiry Date

Exercise price (pence)

No. of Ordinary Shares subject to share awards

2 November 2016

1 March 2019

2 November 2026

0

250,114

9 October 2017

1 March 2020

9 October 2027

0

282,256

3 October 2018

1 March 2021

3 October 2028

0

273,550

 

1 These options are held by Foxberry Ventures Pte. Limited which is wholly owned by David Avgi.

 

 

(ii) LTIP awards (in the form of options in respect of SafeCharge Ordinary Shares) held by Yuval Ziv

 

Date of Grant

Vesting Date

Expiry Date

Exercise price (pence)

No. of Ordinary Shares subject to share awards

2 November 2016

1 March 2019

2 November 2026

0

103,893

9 October 2017

1 March 2020

9 October 2027

0

112,577

3 October 2018

1 March 2021

3 October 2028

0

105,063

 

 

(iii) LTIP awards (in the form of options in respect of SafeCharge Ordinary Shares) held by Tsach Einav

 

Date of Grant

Vesting Date

Expiry Date

Exercise price (pence)

No. of Ordinary Shares subject to share awards

29 January 2017

1 March 2019

29 January 2027

0

115,437

9 October 2017

1 March 2020

9 October 2027

0

150,778

3 October 2018

1 March 2021

3 October 2028

0

140,715

 

(d) Ordinary Shares held by Northenstar Investments Ltd1

 

 

No. of Ordinary Shares of $0.0001 held

% of issued share capital

103,995,185

68.3

 

1 Lynchwood Nominees Limited is the registered holder of 103,995,185 Ordinary Shares which are held as nominee for Northenstar Investments Ltd. Northenstar Investments Ltd is an investment holding company controlled by Teddy Sagi.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

31 May 2019

Contact name:

Lyn Le Prevost

Telephone number:

+44 1481 704 713

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEESDIFLFFUSEFI
Date   Source Headline
7th Jul 20177:00 amRNSDirector/PDMR Shareholding
3rd Jul 201711:10 amRNSTotal Voting Rights
29th Jun 20177:00 amRNSAppointment of CFO and Board Changes
27th Jun 20177:00 amRNSSafeCharge launches Marketplace Manager
6th Jun 20177:00 amRNSTotal Voting Rights
26th May 20177:00 amRNSSafeCharge U.S. Partnership
19th May 201712:16 pmRNSResult of AGM and Trading Update
4th May 20177:00 amRNSTotal Voting Rights
4th Apr 20179:56 amRNSTotal Voting Rights
30th Mar 20173:13 pmRNSBlocklisting Return
23rd Mar 20174:26 pmRNSDirector/PDMR Dealing
21st Mar 20178:11 amRNSDetails of Audiocast
21st Mar 20177:00 amRNSFinal Results
3rd Mar 20177:00 amRNSNotice of presentation
1st Mar 20172:05 pmRNSTotal Voting Rights
28th Feb 20177:00 amRNSNotice of Results
28th Feb 20177:00 amRNSSafeCharge Asian Expansion
2nd Feb 201711:30 amRNSTotal Voting Rights
24th Jan 20177:00 amRNSPurchase of own shares
19th Jan 20177:00 amRNSPre-close trading update
3rd Jan 20172:48 pmRNSTotal Voting Rights
16th Dec 20167:00 amRNSStrategic Investment
2nd Dec 20167:00 amRNSTrading Statement and Strategic Update
1st Dec 201610:00 amRNSTotal Voting Rights
8th Nov 20167:00 amRNSGrant of Awards
3rd Nov 20164:59 pmRNSTotal Voting Rights
11th Oct 20168:35 amRNSHolding(s) in Company
11th Oct 20168:33 amRNSPurchase of own shares
10th Oct 20167:00 amRNSDirectorate Change
5th Oct 20167:05 amRNSLaunch of Tier One Customers
30th Sep 20163:23 pmRNSTotal Voting Rights
19th Sep 20161:39 pmRNSBlocklisting Return
13th Sep 20167:00 amRNSInterim results
5th Sep 201610:00 amRNSChange of Results Date
2nd Sep 20168:00 amRNSTotal Voting Rights
19th Aug 201610:45 amRNSNotice of Results
1st Aug 201611:26 amRNSTotal Voting Rights
8th Jul 20164:12 pmRNSPurchase of own shares
8th Jul 20167:00 amRNSHolding(s) in Company
4th Jul 20166:26 pmRNSHolding(s) in Company
4th Jul 20168:30 amRNSTotal Voting Rights
28th Jun 20167:00 amRNSTrading Statement
14th Jun 20164:17 pmRNSDirector Dealings / Dividend Reinvestment
14th Jun 20168:30 amRNSSale of Investment
1st Jun 201611:31 amRNSTotal Voting Rights
18th May 201612:29 pmRNSResult of AGM
18th May 20167:00 amRNSAGM Statement
3rd May 201611:00 amRNSTotal Voting Rights
25th Apr 20161:39 pmRNSNotice of AGM and Annual Report & Accounts
1st Apr 201610:45 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.